Halozyme Therapeutics, Inc.

Report date
3/31/2026
Quarter
2026 Q1
Filed
5/11/2026
Shares
1,168,666
Value ($000)
75,531
Weight
0.1%
2020 Q2 - 2026 Q1 (15 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).